
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts
Angelo L. Grauel, Beverly Nguyen, David A. Ruddy, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 150
Angelo L. Grauel, Beverly Nguyen, David A. Ruddy, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 150
Showing 1-25 of 150 citing articles:
Exploring tissue architecture using spatial transcriptomics
Anjali Rao, Dalia Barkley, Gustavo S. França, et al.
Nature (2021) Vol. 596, Iss. 7871, pp. 211-220
Open Access | Times Cited: 1077
Anjali Rao, Dalia Barkley, Gustavo S. França, et al.
Nature (2021) Vol. 596, Iss. 7871, pp. 211-220
Open Access | Times Cited: 1077
An introduction to spatial transcriptomics for biomedical research
Cameron G. Williams, Hyun Jae Lee, Takahiro Asatsuma, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 467
Cameron G. Williams, Hyun Jae Lee, Takahiro Asatsuma, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 467
From bulk, single-cell to spatial RNA sequencing
Xinmin Li, Cun‐Yu Wang
International Journal of Oral Science (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 317
Xinmin Li, Cun‐Yu Wang
International Journal of Oral Science (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 317
Overcoming TGFβ-mediated immune evasion in cancer
Daniele V. F. Tauriello, Elena Sancho, Eduard Batlle
Nature reviews. Cancer (2021) Vol. 22, Iss. 1, pp. 25-44
Open Access | Times Cited: 229
Daniele V. F. Tauriello, Elena Sancho, Eduard Batlle
Nature reviews. Cancer (2021) Vol. 22, Iss. 1, pp. 25-44
Open Access | Times Cited: 229
Fibroblasts in cancer: Unity in heterogeneity
Yash Chhabra, Ashani T. Weeraratna
Cell (2023) Vol. 186, Iss. 8, pp. 1580-1609
Closed Access | Times Cited: 199
Yash Chhabra, Ashani T. Weeraratna
Cell (2023) Vol. 186, Iss. 8, pp. 1580-1609
Closed Access | Times Cited: 199
Translational advances in pancreatic ductal adenocarcinoma therapy
Abdel Hosein, Stephanie K. Dougan, Andrew J. Aguirre, et al.
Nature Cancer (2022) Vol. 3, Iss. 3, pp. 272-286
Open Access | Times Cited: 177
Abdel Hosein, Stephanie K. Dougan, Andrew J. Aguirre, et al.
Nature Cancer (2022) Vol. 3, Iss. 3, pp. 272-286
Open Access | Times Cited: 177
Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy
Raisa A. Glabman, Peter L. Choyke, Noriko Sato
Cancers (2022) Vol. 14, Iss. 16, pp. 3906-3906
Open Access | Times Cited: 145
Raisa A. Glabman, Peter L. Choyke, Noriko Sato
Cancers (2022) Vol. 14, Iss. 16, pp. 3906-3906
Open Access | Times Cited: 145
Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment
Mélanie Desbois, Yulei Wang
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 241-258
Closed Access | Times Cited: 138
Mélanie Desbois, Yulei Wang
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 241-258
Closed Access | Times Cited: 138
Cancer-Associated Fibroblasts in Inflammation and Antitumor Immunity
Kilian B. Kennel, Müge Bozlar, Adalbert F. De Valk, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 6, pp. 1009-1016
Open Access | Times Cited: 133
Kilian B. Kennel, Müge Bozlar, Adalbert F. De Valk, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 6, pp. 1009-1016
Open Access | Times Cited: 133
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives
Zengli Fang, Qingcai Meng, Jin Xu, et al.
Cancer Communications (2022) Vol. 43, Iss. 1, pp. 3-41
Open Access | Times Cited: 133
Zengli Fang, Qingcai Meng, Jin Xu, et al.
Cancer Communications (2022) Vol. 43, Iss. 1, pp. 3-41
Open Access | Times Cited: 133
Targeting CAFs to overcome anticancer therapeutic resistance
Phei Er Saw, Jianing Chen, Erwei Song
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 527-555
Closed Access | Times Cited: 127
Phei Er Saw, Jianing Chen, Erwei Song
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 527-555
Closed Access | Times Cited: 127
Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts
Dimitra Kerdidani, Emmanouil Aerakis, Kleio‐Maria Verrou, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 2
Open Access | Times Cited: 120
Dimitra Kerdidani, Emmanouil Aerakis, Kleio‐Maria Verrou, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 2
Open Access | Times Cited: 120
Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers
Liping Pei, Yang Liu, Lin Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 120
Liping Pei, Yang Liu, Lin Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 120
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
Zhenduo Shi, Kun Pang, Zhuo‐Xun Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 105
Zhenduo Shi, Kun Pang, Zhuo‐Xun Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 105
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Tianyi Zhang, Yanxian Ren, Pengfei Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 98
Tianyi Zhang, Yanxian Ren, Pengfei Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 98
Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy
Tian Zhang, Yuanbo Jia, Yang Yu, et al.
Advanced Drug Delivery Reviews (2022) Vol. 186, pp. 114319-114319
Closed Access | Times Cited: 78
Tian Zhang, Yuanbo Jia, Yang Yu, et al.
Advanced Drug Delivery Reviews (2022) Vol. 186, pp. 114319-114319
Closed Access | Times Cited: 78
The advent of immune stimulating CAFs in cancer
Maria Tsoumakidou
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 258-269
Closed Access | Times Cited: 77
Maria Tsoumakidou
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 258-269
Closed Access | Times Cited: 77
STOmicsDB: a comprehensive database for spatial transcriptomics data sharing, analysis and visualization
Zhicheng Xu, Weiwen Wang, Tao Yang, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1053-D1061
Open Access | Times Cited: 60
Zhicheng Xu, Weiwen Wang, Tao Yang, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1053-D1061
Open Access | Times Cited: 60
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
Moumita Kundu, Ramesh Butti, Venketesh K. Panda, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 48
Moumita Kundu, Ramesh Butti, Venketesh K. Panda, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 48
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas
Marina T. Broz, Emily Y. Ko, Kristin Ishaya, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 27
Marina T. Broz, Emily Y. Ko, Kristin Ishaya, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 27
Spatial landscapes of cancers: insights and opportunities
Julia Chen, Ludvig Larsson, Alexander Swarbrick, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 9, pp. 660-674
Closed Access | Times Cited: 20
Julia Chen, Ludvig Larsson, Alexander Swarbrick, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 9, pp. 660-674
Closed Access | Times Cited: 20
Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
Athina Varveri, Miranta Papadopoulou, Zacharias Papadovasilakis, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Athina Varveri, Miranta Papadopoulou, Zacharias Papadovasilakis, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response
Benjamin Jenkins, Ian Tracy, Maria Fernanda Setúbal Destro Rodrigues, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Benjamin Jenkins, Ian Tracy, Maria Fernanda Setúbal Destro Rodrigues, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Cancer associated fibroblasts in cancer development and therapy
Hongyuan Jia, Xingmin Chen, Linling Zhang, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Hongyuan Jia, Xingmin Chen, Linling Zhang, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2